Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Moodys
Baxter
McKinsey
Harvard Business School

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drug Price Trends for OXYBUTYNIN

See Plans and Pricing

« Back to Dashboard

Drug Price Trends for OXYBUTYNIN

Average Pharmacy Cost for OXYBUTYNIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
OXYBUTYNIN 5 MG TABLET 71930-0051-52 0.12921 EACH 2019-11-20
OXYBUTYNIN 5 MG TABLET 71930-0051-13 0.12921 EACH 2019-11-20
OXYBUTYNIN 5 MG TABLET 71930-0051-12 0.12921 EACH 2019-11-20
OXYBUTYNIN 5 MG TABLET 70954-0005-30 0.12921 EACH 2019-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for OXYBUTYNIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
DITROPAN XL 5MG ER TAB J&J obo Janssen Pharmaceuticals, Inc. 50458-0805-01 100 475.68 4.75680 EACH 2019-09-01 - 2024-08-31 Big4
DITROPAN XL 5MG ER TAB J&J obo Janssen Pharmaceuticals, Inc. 50458-0805-01 100 632.28 6.32280 EACH 2019-09-01 - 2024-08-31 FSS
DITROPAN XL 10MG ER TAB J&J obo Janssen Pharmaceuticals, Inc. 50458-0810-01 100 476.16 4.76160 EACH 2019-09-01 - 2024-08-31 Big4
DITROPAN XL 10MG ER TAB J&J obo Janssen Pharmaceuticals, Inc. 50458-0810-01 100 632.92 6.32920 EACH 2019-09-01 - 2024-08-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Boehringer Ingelheim
McKesson
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.